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Passive microwave radiometry (MWR) measures natural emissions in the range 1–10 GHz from proteins,
cells, organs and the whole human body. The intensity of intrinsic emission is determined by
biochemical and biophysical processes. The nature of this process is still not very well known. Infrared
thermography (IRT) can detect emission several microns deep (skin temperature), whereas MWR allows
detection of thermal abnormalities down to several centimeters (internal or deep temperature). MWR is
noninvasive and inexpensive. It requires neither fluorescent nor radioactive labels, nor ionizing or other
radiation. MWR can be used in early drug discovery as well as preclinical and clinical studies.Introduction
The first microwave radiometers were launched on satellites in the
1970s to measure sea surface temperature [1], among other appli-
cations for climate and weather remote monitoring. In 1975,
Barrett and Myers [2] showed that using a microwave radiometer
to identify temperature abnormalities of internal tissue noninva-
sively could help to detect breast cancer. Subsequently, several
studies have confirmed the effectiveness of microwave radiometry
in revealing tissue pathologies [3–7]. The term ‘internal
temperature’ is more commonly used by medical professionals
in the medical literature, whereas physicists use ‘brightness’ tem-
perature. Bones, fatty tissue, breast tissue and other organs have a
different depth of measurement. Muscles and skin have a high
moisture content and a shallower depth.Corresponding author: Goryanin, I. (goryanin@inf.ed.ac.uk)
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https://doi.org/10.1016/j.drudis.2020.01.016 Currently, in biomedicine, infrared radiation (IR) and microwave
radiation are being used for temperature measurements. The main
difference between them is the ability to measure either the skin
temperature (IR can penetrate only several millimeters deep) or
internal tissue temperature (microwaves can record to a depth of 2–
6 cm). In recent years, there has been growing interest in microwave
radiometry (MWR; see Glossary) technology. There are multiple
medical applications targeting the breast [8], brain [9–15], carotid
artery [16–20], brown adipose tissue (BAT) activity [21], rheumatoid
arthritis [22], joints [23], synovial inflammation [24], veins [25],
vesicoureteral reflux [26], the urogenital system [27], back pain
[28,29] and diabetic foot [30]. Use of this method in preclinical
research has been demonstrated in mice [31]. So far, everyone is
convinced that all the heated bodies, and really all the bodies that
surround us, emit electromagnetic waves in the microwave range. So,
everything around us emits a noise signal where power is proportional (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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GLOSSARY
Passive medical microwave radiometry a method
of measuring the intensity of intrinsic electromagnetic
emission from biological objects in 1–10 Ghz range (organs,
tissues, cells, enzymes and other proteins).
Internal (deep) temperature microwave emission
power (W) from human body or other biological objects
converted to temperature in degrees using Plank’s equation.
Skin temperature temperature of the human body
measured in infrared spectrum.
Thermal asymmetry a deep or skin temperature
difference between left and right organs (breast, kidney,
lungs, legs, arms or tissues of organs on left and right side of








EENto the temperature. In the microwave range, the power of thermal
radiation is linearly correlated to body temperature (Eq. 1).
P = k  Tbr  Df (Eq.1)
where P is noise power at the output antenna; Tbr is brightness
temperature; k is the Boltzmann constant; and Df is receiver
bandwidth. However, recent studies show that, in many cases,
non-thermal radiation of living systems in the microwave range
also takes place. To better understand the nature of the phenome-
na several in vitro experiments on cell lines [32], enzymes [33,34]
and proteins [35,37] were performed. Commercially available
equipment: RTM-01-RES (http://www.mmwr.co.uk) (Fig. 1), has
been developed for early diagnosis of cancer and other diseases
[8,9,28]. Technical details about different types of sensors and
antennae have been reported [38–46].
Breast tissue
Breast cancer diagnostics is the most explored application of MWR
technology – by visualization and analysis of left and right breast
deep and skin temperature (Fig. 2). Nine points on each breast, two
axillary points and two reference points should be measured. Each
measurement takes 5–7 s (Fig. 3). Microwave emission asymmetry
between the left and right breast, and difference between skin
(infrared) and internal (microwave) temperature, is used for diag-
nostics. Thermal asymmetry <0.5 C indicates a normal state.
Larger values could indicate pathology and increases >1 C could
indicate malignant tumors. Hot areas of a breast could indicate
inflammation or acute or chronic malignant growth, whereas cold
areas of the breast could be caused by adipose involution, local
anemia, scars and fibrosis, lipoma or a cyst.
FIGURE 1
The RTM-01-RES device. The device and antenna for human body deep and
skin temperature measurements.758 www.drugdiscoverytoday.comThe method has 92  5% sensitivity and 80  5% specificity
for breast cancer detection [8]. This effect could be explained by
the Warburg effect and/or other changes in metabolic and signal-
ing pathways [47–49]. By measuring the temperature of specific
areas of breast tissue, MWR has a potential role in diagnosis,
prognosis and monitoring that has not been widely explored.
The technology is safe, easy to apply and is painless. There are
already good diagnostic tools for breast lumps. MWR has the
added potential to provide more than just a diagnosis and it should
be able to provide information on the rate of vascularity of cancer
and correlate the rate of proliferation. Changes in internal tem-
perature in a cancer should occur early in treatment, before clinical
signs of response are apparent. If we can show that this device can
successfully predict response, this will allow early prediction of
response in individual patients and would have enormous clinical
benefit. Deep tumor temperature changes could be used as an
indicator of aggressiveness, precede structural changes and corre-
late with microvessel density.
Brain
The level of intrinsic radiation of tissues in the microwave range is
only 1012 W; and processing such a weak signal is rather compli-
cated. Nevertheless, use of MWR has made it possible to show that
regions with thermal anomalies are formed over some areas of the
brain in patients with traumatic brain injuries (TBIs). It can also be
used to detect regions with a growing tumor and complications
after stroke during the process of therapeutic hypothermia [10,11].
Validation of MWR has been performed in animal experiments, in
which implanted induction heat sensors were compared with
MWR values. In addition, in neurosurgical patients with
implanted thermal sensors, recorded temperatures were compared
with MRI data. A satisfactory agreement of the data (0.23 C) was
obtained, which made it possible to conduct a large study of
temperature heterogeneity of the brain in healthy individuals,
athletes with lung trachea arthrosis and patients with ischemic
stroke [9]. Subsequently, a large study of the temperature hetero-
geneity of the brain in healthy individuals and patients with
ischemic stroke was carried out [10]. The results of measuring
temperature in stroke patients using magnetic resonance spectros-
copy were controversial [50]. Several mechanisms of microwave
emission and temperature increase in some areas after brain dam-
age have been proposed. According to current thinking, in con-
cussion or other damage to the brain a rapid internal induction of
immune factors occurs. Thus, a neurometabolic cascade develops,
which causes the clinical manifestations [10].
Another hypothesis is that microwave emission is caused by
albumin and other protein denaturation [35]. Hypoalbuminemia
in acute stroke patients is associated with increased mortality and
morbidity. A study of 750 patients with acute cerebral infarction
found hypoalbuminemia, defined as serum albumin level <35 g/l,
in 45.5% of patients. The authors found that low serum albumin
was associated with poor prognosis in acute ischemic stroke
patients and concluded that serum albumin could be used as a
rapid, simple and inexpensive treatment. Currently, the albumin
decrease index (ADI) is measured using electrophoresis, which is
time and labor intensive. Using MWR to monitor albumin dena-
turation in damaged brain in vivo would allow doctors to assess ADI
instantly and to choose appropriate therapies. MWR can also be
Drug Discovery Today Volume 25, Number 4 April 2020 REVIEWS
FIGURE 2
Visualization of microwave emission using RTM-01-RES. Deep and skin temperature field. Red color indicates increase of temperature (tumor was confirmed by
biopsy in right breast). Green color indicates normal state. Blue color indicates deep temperature decrease as a result of clinically confirmed fibrosis.
FIGURE 3





















EENused to monitor albumin degradation after therapeutic interven-
tion [51–53]. Overall, MWR could be used to monitor the course of
therapy, determine the extent of brain damage, calculate optimal
dosage and type of therapeutic intervention and monitor hypo-
thermia and hyperthermia therapies.
Noninvasive carotid artery
Atherosclerosis of the internal carotid artery is an important cause
of disabling ischemic stroke and therefore constitutes a major
medical, social and economic issue; although advances in vascular
imaging modalities allow to stratify patients based on ‘high risk’
indications and there is increasing evidence that inflammation is a
key factor in the initiation, progression and destabilization of
plaques. MWR is used to measure the level of inflammation in
carotid arteries [16,17]. In a recent study [18], 300 patients from
three centers with significant coronary artery disease were includ-
ed in this study. Both carotid arteries were measured using ultra-
sound and MWR for at least 2 years. Temperature difference (DT)
was defined as maximal minus minimal deep temperature along
each carotid artery. Fatty plaques exhibited higher internal tem-
perature heterogeneity compared with mixed and calcified pla-
ques. In recent publications [19,20] it was shown that MWR could
contribute significantly to primary and secondary prevention of
stroke.
Back pain
Pain is highly subjective in nature. The measurement of intensity
is primarily dependent on patient sensation. The correlation
between the pain syndrome and the results of MWR was reported
in the diagnosis of muscular-joint disorders of cervicogenic head-
ache [29]. In the area of the projection of back pain, the tempera-
ture of deep structures, in comparison with other areas, could be
elevated, reduced or normal. So, back pain syndromes can be
assessed by MWR. This enables more-precise diagnosis including
localization of pain and discrimination of its intensity. It was
shown that temperature increases with low-back pain (LBP) sever-
ity and MWR allows the objective assessment of the magnitude of
clinical symptoms [28]. Recently, clinical studies of 48 LBP
patients showed that internal temperature is highest in patients
with LBP who report the most severe pain and in whom MWR was
performed within the first week after the patient experienced an
exacerbation. It was shown that MWR allows an objective assess-
ment of the magnitude of clinical symptoms in patients with LBP
and that the method shows promise for measuring the severity of
pain and for predicting the duration of exacerbation and time for
recovery [28].
Venous thrombosis
There are multiple publications and patents on this disease [25].
The MWR measurements are conducted at 12 points for >100
patients. The temperature is sequentially measured at symmetrical
points on the posterior surface of the legs of the patient in the
supine position and standing with a surface infrared sensor and a
deep microwave sensor. The diagnosis is made on the following
criteria: the axial gradient of deep temperatures is reduced in a
standing position and is absent in a prone position; decrease and
absence of an axial gradient of deep temperatures associated with
an increase in deep temperature along the medial surface of the760 www.drugdiscoverytoday.comlower leg in the middle and lower third sensitivity 100% and
specificity 81.3% [25]. It was shown that MWR can be used for
early-stage diagnosis of acute thrombosis and to observe the
dynamics of the inflammatory process.
Diabetic foot
Diagnosis of vascular involvement in diabetic foot ulceration
(DFU) remains challenging. A proof-of-concept, multicenter fea-
sibility study of MWR for noninvasive differential diagnosis of
arterial disease in diabetic patients with suspected critical limb
ischemia (CLI) in subjects with DFU was carried out. Eighty
participants [30] were divided into four groups (group N: normal
control subjects; group DN: participants with diabetes and verified
neuropathic ulcers without vascular involvement; group DC: par-
ticipants with diabetes and CLI and group NDC: participants with
CLI without diabetes). Vascular disease was confirmed with angi-
ography. The mean deep tissue temperatures at various predeter-
mined foot sites were measured. Temperatures recorded in the
vicinity of the foot ulcers of participants with diabetes and CLI
were similar to those with CLI without diabetes but significantly
lower than in subjects with neuropathic ulcers without vascular
involvement and normal controls (group DC: 29.30  1.89 C vs
group NDC: 29.18  1.78 C vs group N: 33.01  0.45 C vs group
DN: 33.39  1.37 C). According to receiver operating characteris-
tic (ROC) analysis, cut-off temperature value to diagnose CLI was
31.8 C, with a sensitivity of 100% and specificity of 88.37%.
Tissue temperatures in the vicinity of the ulcers were significantly
lower in participants with CLI, with or without diabetes, compared
with nonischemic controls.
Brown adipose tissue
Recently, MWR technology was used to monitor BAT activity and
identify therapies for diabetes, metabolic syndrome, obesity and
aging [54,55]. It was shown that activation of BAT is a powerful
remedy to ameliorate hyperlipidemia and protect from atheroscle-
rosis [56]; and that brown fat activation reduces triglyceride and
low-density lipoprotein (LDL) levels and attenuates diet-induced
atherosclerosis progression. The mean radiometry result collected
during BAT maximization was 33.2  1.5 C at points designated
as active and 32.7  1.3 C at points designated as inactive. It was
shown that MWR could be used to detect active BAT without a
radiotracer injection, and noninvasively [21].
Urology
MWR was used to determine the microwave emission at nine
points for the left and right kidney in the upper, intermediate
and lower segments, which increases the sensitivity diagnosis of
pathology [27]. First, MWR tests were performed in 30 healthy
individuals and then in 86 patients with acute pyelonephritis.
Healthy volunteers demonstrated the absence of thermal asym-
metry, the temperatures of the kidneys differ with 34 <0.3C.
This temperature was considered as the physiological normal. In
acute nonobstructive pyelonephritis, the thermal asymmetry av-
erage is 0.9C; or 1.5C among patients with acute obstructive
pyelonephritis. These data provide evidence of MWR value at the
early stages of the inflammatory process in renal tissue, when
ultrasound has not yet detected structural changes in the renal
parenchyma (only 64%). There were similar results in studies of 93
Drug Discovery Today Volume 25, Number 4 April 2020 REVIEWS
FIGURE 4
Microwave passive antennae (disk and wire) for in vitro and cell culture












patients with acute nonobstructive pyelonephritis: 55 with acute
obstructive, 19 with acute purulent and 140 without urological
disease. The increase in deep temperature in acute purulent ob-
structive pyelonephritis was >1.3C and in acute obstructive
pyelonephritis it was 0.9–1.3 C. In healthy individuals the differ-
ence between the kidneys was <0.3 C. For prostate mean tem-
peratures in the suprapubic area in patients with acute prostatitis it
was 37.1  0.2 C, for prostate abscess it was 38.0  0.3 C and for
prostate cancer it was 36.4 0.2 C. Healthy individuals in the
older age group have decreased deep temperature in the perineal
area from 36.4 0.2 C (age 18–25 years) to 36.0 0.2 C (age 66–
75 years). Studies show that MWR could be used for diagnostics in
different forms of acute pyelonephritis, renal colic and acute
inflammatory diseases of the prostate [27].
Whole-body scan
The biological aging markers [57] were revealed in the form of
MWR thermal asymmetry in the projection zones of the following
organs: the thyroid gland eight points; the liver 18 points; the
kidneys nine points on each side; the spine (along the median and
paravertebral lines in the cervical and thoracolumbar sections) 48
points; knee and hip joints nine points on each side. An average
temperature was obtained for each zone. The average deep tem-
perature, taken as a standard, was compared with the temperature
at each point in the zone. When the value of the indicator was 0.6–
1.0C a dysfunctional type of thermal asymmetry was determined.
The method enables identification of individuals with an acceler-
ated rate of aging and the individualization of therapeutic mea-
sures in this group of patients.
Preclinical applications
A special antenna was designed for preclinical studies to acquire
fundamentally new information about the processes of metabo-
lism, perfusion (microcirculation) and cellular kinetics in malig-
nancies in animal models [31].
Cell line applications
Microwave emission (brightness temperature) of a suspension of
cells of follicular carcinoma of the thyroid gland during necrosis
was monitored. It was shown that, when necrosis occurs in a cell
suspension, the microwave emission increases, whereas the IR
temperature does not change in the infrared range [32]. It was
shown that cell necrosis could lead to a non-equilibrium state of
the medium, expressed in a change in the microwave emission
ratio. The authors hypothesized that the effect can be associated
with the restructuring of the intracellular and intercellular cells.
Cell necrosis in the microwave and infrared range can be moni-
tored and used to control the dynamics of necrosis.
In vitro applications
Using smaller microwave antennae with the USB powered sensor
RTM-01-RES and a specialized antenna (Fig. 4), a microwave
emission change of 1.5–2 C for aqueous albumin solution was
found during its thermal denaturation. In addition, protein dena-
turation kinetics were determined [33]. The same phenomena
were observed during chemical denaturation of egg white, which
is well-known to contain 10% protein including albumin. The 2 C
increase of microwave emission was observed during the first 20 safter alcohol addition, whereas infrared temperature rose much
slower, taking minutes [36].
Microwave emission has been observed as well – in the process
of hydroxylation of enzyme CYP102 A1 [34]. The 0.5–2 C increase
within 10–20 s in multi-pulse mode follows the addition of co-
substrate NADPH (0.2 mM) to the system containing lauric acid
(0.5 mM), and enzyme 1010 to 108 M. A single-pulse mode
(synchronized pulse radiation) at 106M concentration of enzyme
was observed. This effect could be explained using biomaser
hypothesis. Also, the synchronized pulsed radiation could indicate
the generation of qubits in a biological system [34]. The similar
0.5 C microwave emission increase in passive mode and 2 C in
excitation mode was observed in a solution of horseradish peroxi-
dase (HRP). Luminol (103 M) was added to the solution of HRP
(106 M) and oxidization of the H2O2 substrate (10
4 M) within 20
s in excitation mode has been observed [33].
Each HRP and CYP102 A1 reaction is accompanied by the
fluctuation of the protein globule with approximately the same
amplitude (in the order of 0.08 nm). The microwave emission
effect could be explained by rotational transitions of molecules
and ions excited during catalysis (OH, H2O and H2O2) in GHz
(the change in the ratio between para- and ortho-isomers of H2O in
GHz), with increased mobility of the protein globule during the
catalytic reaction [33,34].
MWR does not require any isotopes or fluorescent labels. It is
simple and low-cost in comparison with calorimeters and opticalwww.drugdiscoverytoday.com 761








EENspectrometers and provides new opportunities for R&D studies.
Measurements can be recorded every 4 s and time series data can be
analyzed, which is very important for enzyme kinetics studies. The
method could be particularly useful in enzymatic and metabolic
research, and for inhibitor screening. Microwave emission could
be used as a direct readout to measure enzyme–substrate binding
and inhibition effects. Further experiments with changing sub-
strate and inhibitor concentrations are required to calibrate the
method for particular biochemical systems. It is possible to deter-
mine kinetic parameters of biochemical processes. So, the method
could be used to obtain data for modeling of biochemical reaction
and quantitative dynamics modeling of cells, tissues and organs.
AI for microwave radiometry: big data
Large volumes of microwave data can be generated inexpensively in
comparison with other temperature measurements. An expert sys-
tem has been developed to analyze these data [58,59] and, recently,
AI deep learning has been applied to provide advice regarding the
diagnosis of breast cancer. The dataset consists of 363 pairs of
mammary glands of which 77 are classified as healthy or low risk
(labeled as class 0) and 286 classified as potentially cancerous or high
risk (labeled as class 1). The Deep Neural Networks (DNN) was able to
obtain a G-mean loss of 0.2843, accuracy of 0.7703, sensitivity of
0.8103 and specificity of 0.625. The prediction will be increased
when more data will be used in a training set. A human annotated
dataset >2000 healthy and diseased breasts is under construction.
Recently, we initiated a worldwide initiative to collect MWR data
from patients and healthy people.
Concluding remarks
It was shown that MWR has many advantages compared with IR
thermography (IRT). MWR is not as expensive as fMRI. It benefits
from passive sensors, a lack of radiation, no side-effects and high
sensitivity. It can detect pathologies deep in the human body at an
early stage and visualize and analyze results with advisory diag-
nostics software. It does not require any consumables. MWR could762 www.drugdiscoverytoday.combe considered the ‘poor people’s fMRI’. This is a reason why MWR
is very popular in developing countries but not in the West.
We have demonstrated that MWR can be used at all stages of the
pharmaceutical R&D process, and as a rapid and cost-effective
clinical diagnostic, as well as to monitor effects of therapies. As a
companion diagnostic tool, MWR can increase the informative-
ness of existing X-ray and ultrasound diagnostics at the early stages
of diseases. The high-resolution data obtained could be used for
systems biology, quantitative systems pharmacology and deep
neural network models to make predictions. Such models could
be used for preclinical research, clinical trials, better diagnostics
and monitoring effects of treatment.
Recently, the FDA issued a warning that IRT cannot be used as a
diagnostic tool for breast cancer, because IR can only measure skin
temperature [60]. MWR is an alternative technology that could be
used for breast cancer diagnostics and screening programs from
childhood. The technology is currently popular among traditional
and holistic medicine practitioners, as well as beauty salon profes-
sionals. With the proven hardware, associated AI software and
more clinical evidence we expect MWR will be used worldwide in
the near future. More clinical studies and collaboration between
academia and the pharma industry are required in different thera-
peutic areas.
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